MediPrint® Ophthalmics, a clinical-stage ophthalmic drug delivery company, continues to advance its innovative glaucoma program following the successful completion of its Phase 2b clinical trial for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback